Imaging services provider American Shared Hospital Services ofSan Francisco failed to make the semiannual interest payment thatwas due last month on senior subordinated notes. The firm is discussingways to restructure the debt with its investment banker.
Imaging services provider American Shared Hospital Services ofSan Francisco failed to make the semiannual interest payment thatwas due last month on senior subordinated notes. The firm is discussingways to restructure the debt with its investment banker. Earlierin April, ASHS repurchased $6 million in senior subordinated notesfrom two holders at a discount.
ASHS, which is predominantly a mobile medical imaging company,has a cash flow problem due to losses incurred over the last twoyears. The company is exploring other financing options apartfrom debt restructuring, including the sale of assets and possiblejoint ventures, according to the ASHS 1990 annual report, releasedlast month.
The firm's primary magnetic resonance imaging business is profitable.ASHS has been loosing money, however, with its computed tomography,ultrasound and nuclear medicine businesses, said Ernest A Bates,chairman.
ASHS lost $3.6 million in fiscal 1990 (end-December), comparedto $2.7 million in 1989. Revenues were $61.5 million last year,up 18% from $52.3 million in 1989.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
2 Commerce Drive
Cranbury, NJ 08512